← Leaderboards
Roy L Silverstein
Weill Medical College Of Cornell Univ
$14,739,965
Attributed
$17,913,438
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.3M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$39,993,602 · 16
By mechanism
P50$14,801,149 · 2
P01$13,244,504 · 5
R01$11,141,233 · 8
T32$806,716 · 1
Top collaborators
- Weiguo Cui4 shared
- Craig N Morrell4 shared
- Yiliang Chen3 shared
- Komal Sodhi3 shared
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- Frederick R. Maxfield$24,460,727
- David P Hajjar$13,911,032
- Julianne L Imperato-McGinley$179,286,606
- Maria Febbraio$3,595,118
- Enrique J Rodriguez-Boulan$27,052,115
Others in their field
Top investigators on “Ligands”
- John Damon Chodera · Sloan-Kettering Inst Can Research$39,009,297
- Keith W Miller · Massachusetts General Hospital$35,506,092
- Ian A Wilson · Scripps Research Institute, The$35,392,112
- Bryan L Roth · Univ Of North Carolina Chapel Hill$32,442,555
- Edward Franklin Plow · Cleveland Clinic Foundation$32,215,714
- Helen M Berman · Rutgers University New Brunswick$32,076,400
Research focus
LigandsSignal TransductionCd36 GeneCellsReceptorPublishingAtherosclerosisIn VivoMediatingProteinsDiabetes MellitusInflammatoryProgramsInflammationLinkChronicPathway InteractionsResponseScavenger ReceptorOxidized Low Density LipoproteinRegulationMalignant NeoplasmsGeneticMacrophage
Grant awards (62)
NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis$534,197
R01 · FY2025 · HL · contact PI
NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis$523,513
R01 · FY2024 · HL · contact PI
Pim1 kinase coordinates PPAR gamma pathway and mitochondrial function to mediate pro-atherogenic responses in macrophages$408,595
R01 · FY2024 · HL · contact PI
NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis$547,197
R01 · FY2023 · HL · contact PI
Pim1 kinase coordinates PPAR gamma pathway and mitochondrial function to mediate pro-atherogenic responses in macrophages$416,932
R01 · FY2023 · HL · contact PI
ERK5 and CD36 link oxidative stress to platelet dysfunction and ischemic injury$632,045
R01 · FY2022 · HL · contact PI
Pim1 kinase coordinates PPAR gamma pathway and mitochondrial function to mediate pro-atherogenic responses in macrophages$416,932
R01 · FY2022 · HL · contact PI
ERK5 and CD36 link oxidative stress to platelet dysfunction and ischemic injury$632,045
R01 · FY2021 · HL · contact PI
Pim1 kinase coordinates PPAR gamma pathway and mitochondrial function to mediate pro-atherogenic responses in macrophages$423,432
R01 · FY2021 · HL · contact PI
ERK5 and CD36 link oxidative stress to platelet dysfunction and ischemic injury$632,045
R01 · FY2020 · HL · contact PI
ERK5 and CD36 link oxidative stress to platelet dysfunction and ischemic injury$645,045
R01 · FY2019 · HL · contact PI
4R01HL111614-04: Mechanistic Role of CD36 in Thrombosis Supplement Cost Extension$45,146
R01 · FY2017 · HL · contact PI
Mechanistic Role of CD36 in Thrombosis$430,012
R01 · FY2016 · HL · contact PI
Mechanistic Role of CD36 in Thrombosis$422,260
R01 · FY2015 · HL · contact PI
Mechanistic Role of CD36 in Thrombosis$374,551
R01 · FY2014 · HL · contact PI
Mechanistic Role of CD36 in Thrombosis$45,214
R01 · FY2014 · HL · contact PI
Mechanistic Role of CD36 in Thrombosis$368,851
R01 · FY2013 · HL · contact PI
Regulation of the anti-antiangiogenic switch by CD36, Thrombospondin, and HRGP$388,330
R01 · FY2012 · HL · contact PI
Candidate Genes Affecting Adolescent Metabolic Syndrome$570,703
R01 · FY2011 · DK · contact PI
Regulation of the anti-antiangiogenic switch by CD36, Thrombospondin, and HRGP$392,500
R01 · FY2011 · HL · contact PI
INFLAMMATORY CELL SIGNALING BY CD36$391,986
P01 · FY2011 · HL · contact PI
ADMINISTRATIVE CORE$135,850
P01 · FY2011 · HL · contact PI
Genetic and Cellular Determinants of Arterial Thrombosis$2,700,496
P50 · FY2010 · HL · contact PI
Oxidized Phospholipids in Vascular Pathobiology$2,281,238
P01 · FY2010 · HL · contact PI
ROLE OF CD 36 AS PRO-THROMBOTIC PLATELET SURFACE RECEPTOR$396,832
P50 · FY2010 · HL · contact PI
Regulation of the anti-antiangiogenic switch by CD36, Thrombospondin, and HRGP$392,500
R01 · FY2010 · HL · contact PI
INFLAMMATORY CELL SIGNALING BY CD36$392,065
P01 · FY2010 · HL · contact PI
ADMINISTRATIVE CORE$135,877
P01 · FY2010 · HL · contact PI
Genetic and Cellular Determinants of Arterial Thrombosis$2,636,849
P50 · FY2009 · HL · contact PI
Oxidized Phospholipids in Vascular Pathobiology$2,281,679
P01 · FY2009 · HL · contact PI
Regulation of the anti-antiangiogenic switch by CD36, Thrombospondin, and HRGP$392,500
R01 · FY2009 · HL · contact PI
INFLAMMATORY CELL SIGNALING BY CD36$392,140
P01 · FY2009 · HL · contact PI
ROLE OF CD 36 AS PRO-THROMBOTIC PLATELET SURFACE RECEPTOR$388,009
P50 · FY2009 · HL · contact PI
ADMINISTRATIVE CORE$135,903
P01 · FY2009 · HL · contact PI
Genetic and Cellular Determinants of Arterial Thrombosis$2,523,558
P50 · FY2008 · HL · contact PI
Oxidized Phospholipids in Vascular Pathobiology$2,282,109
P01 · FY2008 · HL · contact PI
Regulation of the anti-angiogenic switch by CD36, Thrombospondin, and HRGP$392,500
R01 · FY2008 · HL · contact PI
INFLAMMATORY CELL SIGNALING BY CD36$392,215
P01 · FY2008 · HL · contact PI
ROLE OF CD 36 AS PRO-THROMBOTIC PLATELET SURFACE RECEPTOR$371,862
P50 · FY2008 · HL · contact PI
ADMINISTRATIVE CORE$135,927
P01 · FY2008 · HL · contact PI
Genetic and Cellular Determinants of Arterial Thrombosis$2,520,364
P50 · FY2007 · HL · contact PI
Oxidized Phospholipids in Vascular Pathobiology$2,323,399
P01 · FY2007 · HL · contact PI
INFLAMMATORY CELL SIGNALING BY CD36$399,188
P01 · FY2007 · HL · contact PI
ROLE OF CD 36 AS PRO-THROMBOTIC PLATELET SURFACE RECEPTOR$372,123
P50 · FY2007 · HL · contact PI
ADMINISTRATIVE CORE$139,560
P01 · FY2007 · HL · contact PI
Genetic and Cellular Determinants of Arterial Thrombosis$2,530,472
P50 · FY2006 · HL · contact PI
ROLE OF CD 36 AS PRO-THROMBOTIC PLATELET SURFACE RECEPTOR$360,584
P50 · FY2006 · HL · contact PI
Vascular signaling via scavenger receptors$373,279
P01 · FY2005 · HL
CD36 /TSP-1: Novel antiangiogenic switch mechanism$234,491
P01 · FY2005 · HL
INSTITUTIONAL RESEARCH FELLOWSHIP AWARD IN HEMATOLOGY$109,971
T32 · FY2003 · HL
INSTITUTIONAL RESEARCH FELLOWSHIP AWARD IN HEMATOLOGY$309,544
T32 · FY2002 · HL
MOLECULAR MECHANISMS OF RPE PHAGOCYTOSIS--ROLE OF CD36$283,746
R01 · FY2002 · EY
CD36 /TSP-1: Novel antiangiogenic switch mechanism$214,593
P01 · FY2002 · HL
Vascular signaling via scavenger receptors$157,506
P01 · FY2002 · HL
MOLECULAR MECHANISMS OF RPE PHAGOCYTOSIS--ROLE OF CD36$275,481
R01 · FY2001 · EY
Vascular signaling via scavenger receptors$157,506
P01 · FY2001 · HL
INSTITUTIONAL RESEARCH FELLOWSHIP AWARD IN HEMATOLOGY$118,203
T32 · FY2001 · HL
CD36 /TSP-1: Novel antiangiogenic switch mechanism$0
P01 · FY2001 · HL
CELLULAR ATTACHMENT AND ADHESIVE RECEPTORS$287,993
P01 · FY2000 · HL
MOLECULAR AND CELL BIOLOGY OF CD36 A TSP RECEPTOR$287,503
R01 · FY2000 · HL
INSTITUTIONAL RESEARCH FELLOWSHIP AWARD IN HEMATOLOGY$268,998
T32 · FY2000 · HL
MOLECULAR MECHANISMS OF RPE PHAGOCYTOSIS--ROLE OF CD36$267,458
R01 · FY2000 · EY